Amygdalin synergizes with the TNF-α monoclonal antibody infliximab to modulate HSP90 and related necro-inflammatory/oxidative stress pathways in a rat model of hepatic I/R
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-03 · 399 (5) · 7643-7657
DOI: 10.1007/s00210-025-04866-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 17.12.2025. Verfasst von Reem A Mohamed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), 26 July Mehwar Road Intersection With Wahat R…. Hauptthemen laut MEDLINE: HSP90 Heat-Shock Proteins, Infliximab, Amygdalin, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: October University for Modern Sciences and Arts.
Abstract (Originalsprache)
Hepatic ischemia/reperfusion (I/R) injury remains a major limitation in liver surgery and transplantation. Amygdalin, a natural glycoside, is known for its antioxidant, anti-inflammatory, and hepatoprotective properties, but its combination with conventional agents is not studied. Accordingly, this study explores a combinatorial approach using a small dose of amygdalin (5 mg/kg) and low-dose infliximab (1.5 mg/kg), a tumor necrosis factor (TNF)-α inhibitor, as a pre-treatment to alleviate I/R-induced liver injury. It also investigates the unexamined role of heat shock protein (HSP)-90 in the modulation of necro-inflammatory pathways during hepatic ischemia/reperfusion injury. Rats were divided into six groups: sham, I/R, infliximab (1.5 and 3 mg/kg), amygdalin (5 mg/kg), and a combination of infliximab (1.5 mg/kg) with amygdalin. Treatments were administered intraperitoneally for three days before I/R induction. Both monotherapies and the combination significantly reduced hepatic expression of HSP90, TNF-α, and phosphorylated-mixed lineage kinase domain-like protein ( p-MLKL ), while restoring oxidative balance as evidenced by modulation of nuclear factor erythroid 2-related factor 2 (Nrf2), malondialdehyde (MDA), and superoxide dismutase (SOD). The combination therapy additionally suppressed nuclear factor kappa B (NF-κB) in a synergistic manner and enhanced Nrf2 expression compared to amygdalin monotherapy. Correlation analysis revealed strong associations between markers of necroinflammation and oxidative stress, reinforcing the mechanistic interplay between these pathways. HSP90 emerged in the current study as an intermediate modulator linking necroinflammation to oxidative responses. Importantly, the combined therapy exerted a synergistic effect by effectively modulating HSP90 and associated signaling cascades, underscoring its potential as a superior therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), 26 July Mehwar Road Intersection With Wahat Road, 6th October City, Egypt. Ralia@msa.edu.eg.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Sadat City (USC), Sadat City, 32897, Egypt.
- Department of Pharmacology, Faculty of Pharmacy, The British University in Egypt, Cairo, Egypt.
- Drug Research and Development Group (DRD-G), Research Center of Excellence, The British University in Egypt, Cairo, Egypt.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt.
ORCID-Profile: Reem A Mohamed
Förderung
- October University for Modern Sciences and Arts
Zitieren
APA
Mohamed, R. A., Ghoneim, M. E., Tawfiq, R. A., & El Sayed, N. F. (2026). Amygdalin synergizes with the TNF-α monoclonal antibody infliximab to modulate HSP90 and related necro-inflammatory/oxidative stress pathways in a rat model of hepatic I/R. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(5), 7643-7657. https://doi.org/10.1007/s00210-025-04866-6
Vancouver
Mohamed RA, Ghoneim ME, Tawfiq RA, El Sayed NF. Amygdalin synergizes with the TNF-α monoclonal antibody infliximab to modulate HSP90 and related necro-inflammatory/oxidative stress pathways in a rat model of hepatic I/R. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(5):7643-7657. doi:10.1007/s00210-025-04866-6
BibTeX
@article{Mohamed2026,
author = {Mohamed, Reem A and Ghoneim, Mai El-Sayed and Tawfiq, Rasha A and El Sayed, Nermein F},
title = {Amygdalin synergizes with the TNF-α monoclonal antibody infliximab to modulate HSP90 and related necro-inflammatory/oxidative stress pathways in a rat model of hepatic I/R},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {5},
pages = {7643--7657},
doi = {10.1007/s00210-025-04866-6}
}
EUVIMED